Medical Devices

Lancens Technology Chosen to Drive Future of Connected Healthcare Solutions

Partnership with Healthcare Impact Alliance Aims to Advance Interoperability and Patient-Centered Care Technologies....

VUNO’s AI Cardiac Risk System Gains CE MDR and UKCA Certifications

Milestone Approvals Enable European and UK Market Access for AI-Based Cardiac Arrest Prediction Tool...

EDGe Surgical Secures $1.3M+ to Drive Growth and Product Expansion

Funding to Fuel Commercial Scale-Up and Launch of New Ortho EDG Surgical Instruments in U.S. and International Markets....

AutoIVF Announces Syndicated Investment Round, Led by Vitrolife AB (publ)

Vitrolife AB Leads Syndicated Funding to Accelerate Development of AutoIVF’s Automated In Vitro Fertilization Platform...

Lightcast Launches Envisia™ Platform to Revolutionize Antibody Discovery

Limited Release Targets Biotech Innovators with Real-Time Droplet-Based Assays to Accelerate Therapeutic Discovery...

Osteotec Signs Exclusive Distribution Agreement with icotec ag to Advance Spine Tumour Therapy in Great Britain

The exclusive distribution agreement introduces icotec's innovative BlackArmor® Carbon/PEEK implants, advancing treatment options for spinal tumour patients in Great Britain....

Teal Health’s Teal Wand™ Receives FDA Approval as First At-Home Cervical Cancer Screening Device

Breakthrough self-collection technology offers women a more comfortable, accessible alternative to traditional in-clinic screenings, aiming to boost early detection and public health outcomes. ...

Mediso Advances Cryogen-Free MRI with Tech Transfer from SSI

Strategic milestone enables in-house magnet manufacturing for systems up to 9.4T ...

Longhorn Validates PrimeStore® MTM for Safe Inactivation of Deadly Pathogens

NIH-backed study validates FDA-cleared diagnostic transport medium as a critical tool for safe virus handling and global biosurveillance....

OmniAb Launches xPloration® Partner Access Program to Accelerate Antibody Discovery Collaborations

New initiative aims to provide early-stage biotech and academic partners with greater access to OmniAb’s antibody discovery technologies, supporting innovation and therapeutic development. ...